Long-term escherichia coli asymptomatic bacteriuria among women with diabetes mellitus

Clinical Infectious Diseases

Volumn 49, Issue 4, 2009, Pages 491-497

  Dalal, Shona ^a   Nicolle, Lindsay ^a,b   Marrs, Carl F ^a   Zhang, Lixin ^a   Harding, Godfrey ^a,b   Foxman, Betsy ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; VIRULENCE FACTOR;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; ASYMPTOMATIC BACTERIURIA; BACTERIAL COLONIZATION; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; CANADA; CLINICAL TRIAL; COMMENSAL ESCHERICHIA COLI; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC PATIENT; DOT HYBRIDIZATION; ESCHERICHIA COLI; FECES; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT INFECTION; SYMPTOMATOLOGY; TREATMENT OUTCOME; UROPATHOGENIC ESCHERICHIA COLI;

ADULT; ANTI-BACTERIAL AGENTS; BACTERIAL TYPING TECHNIQUES; BACTERIURIA; CLUSTER ANALYSIS; DIABETES COMPLICATIONS; DNA FINGERPRINTING; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; FEMALE; GENOTYPE; HUMANS; LONGITUDINAL STUDIES; MANITOBA; MIDDLE AGED; NUCLEIC ACID HYBRIDIZATION; RANDOM AMPLIFIED POLYMORPHIC DNA TECHNIQUE; TIME FACTORS; TREATMENT OUTCOME; VIRULENCE FACTORS;

EID: 67651102443     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/600883     Document Type: Article

References (23)

1. Stapleton A. Urinary tract infections in patients with diabetes. Am J Med 2002; 113(Suppl 1A):80S-4S.
2. Zhanel GG, Nicolle LE, Harding GK; The Manitoba Diabetic Urinary Infection Study Group. Prevalence of asymptomatic bacteriuria and associated host factors in women with diabetes mellitus. Clin Infect Dis 1995;21:316-22.
3. Harding GK, Zhanel GG, Nicolle LE, Cheang M. Antimicrobial treatment in diabetic women with asymptomatic bacteriuria. N Engl J Med 2002;347:1576- 83.
4. Geerlings SE, Stolk RP, Camps MJ, et al. Consequences of asymptomatic bacteriuria in women with diabetes mellitus. Arch Intern Med 2001; 161:1421-7.
5. Ribera MC, Pascual R, Orozco D, Perez Barba C, Pedrera V, Gil V. Incidence and risk factors associated with urinary tract infection in diabetic patients with and without asymptomatic bacteriuria. Eur J Clin Microbiol Infect Dis 2006; 25:389-93.
6. Meiland R, Geerlings SE, Stolk RP, Netten PM, Schneeberger PM, Hoepelman AI. Asymptomatic bacteriuria in women with diabetes mel- litus: effect on renal function after 6 years of follow-up. Arch Intern Med 2006; 166:2222-7.
7. Ronald A, Ludwig E. Urinary tract infections in adults with diabetes. Int J Antimicrob Agents 2001 ; 17:287-92.
8. Zhang L, Foxman B. Molecular epidemiology of Escherichia coli mediated urinary tract infections. Front Biosci 2003; 8:e235-4.
9. Johnson J. Virulence factors in Escherichia coli urinary tract infection. Clin Microbiol Rev 1991; 4:80-128.
10. Geerlings SE, Stolk RP, Camps MJ, Netten PM, Collet TJ, Hoepelman AI. Risk factors for symptomatic urinary tract infection in women with diabetes. Diabetes Care 2000; 23:1737-41.
11. Geerlings SE, Meiland R, van Lith EC, Brouwer EC, Gaastra W, Hoe- pelman AI. Adherence of type 1-fimbriated Escherichia coli to uroe- pithelial cells: more in diabetic women than in control subjects. Diabetes Care 2002;25:1405-9.
12. Boyko EJ, Fihn SD, Scholes D, Abraham L, Monsey B. Risk of urinary tract infection and asymptomatic bacteriuria among diabetic and non- diabetic postmenopausal women. Am J Epidemiol 2005; 161:557-64.
13. Hulton CS, Higgins CF, Sharp PM. ERIC sequences: a novel family of repetitive elements in the genomes of Escherichia coli, Salmonella ty- phimurium and other enterobacteria. Mol Microbiol 1991;5:825-34.
14. Zhang L, Gillespie BW, Marrs CF, Foxman B. Optimization of a fluorescent-based phosphor imaging dot blot DNA hybridization assay to assess E. coli virulence gene profiles. J Microbiol Methods 2001;44: 225-33.
15. Marrs CF, Zhang L, Tallman P, et al. Variations in 10 putative uro- pathogen virulence genes among urinary, faecal and peri-urethral Esch- erichia coli. J Med Microbiol 2002; 51:138-42.
16. Hooton TM, Scholes D, Stapleton AE, et al. A prospective study of asymptomatic bacteriuria in sexually active young women. N Engl J Med 2000; 343:992-7.
17. Holden NJ, Gally DL. Switches, cross-talk and memory in Escherichia coli adherence. J Med Microbiol 2004; 53:585-93.
18. Wullt B, Bergsten G, Samuelsson M, Svanborg C. The role of P fimbriae for Escherichia coli establishment and mucosal inflammation in the human urinary tract. Int J Antimicrob Agents 2002; 19:522-38.
19. Hull RA, Rudy DC, Donovan WH, Wieser IE, Stewart C, DarouicheRO. Virulence properties of Escherichia coli 83972, a prototype strain associated with asymptomatic bacteriuria. Infect Immun 1999;67:429-32.
20. Zdziarski J, Svanborg C, Wullt B, Hacker J, Dobrindt U. Molecular basis of commensalism in the urinary tract: low virulence or virulence attenuation? Infect Immun 2008; 76:695-703.
21. Klemm P, Hancock V, Schembri MA. Mellowing out: adaptation to commensalism by Escherichia coli asymptomatic bacteriuria strain 83972. Infect Immun 2007; 75:3688-95.
22. Vranes J, Kruzic V, Sterk-Kuzmanovic N, Schonwald S. Virulence characteristics of Escherichia coli strains causing asymptomatic bacteriuria. Infection 2003;31:216-20.
23. Geerlings SE, Brouwer EC, Gaastra W, Stolk R, Diepersloot RJ, Hoe- pelman AI. Virulence factors of Escherichia coli isolated from urine of diabetic women with asymptomatic bacteriuria: correlation with clinical characteristics. Antonie Van Leeuwenhoek 2001; 80:119-27.